Reddit Emerges as a Major Winner in the Shift to AI-Powered Search 
L3Harris Nears $500M Deal to Sell Majority Stake in Space Propulsion Portfolio to AE Industrial 
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns 
Nvidia Unveils Rubin Platform to Power Next Wave of AI Infrastructure 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
TSMC Shares Hit Record High as Goldman Sachs Raises Price Target on AI Demand Outlook 
Intel Unveils Panther Lake AI Laptop Chips at CES 2025, Marking Major 18A Manufacturing Milestone 
Dell Revives XPS Laptop Lineup With New XPS 14 and XPS 16 to Boost Premium PC Demand 
Cathay Pacific Shares in Focus as Air China Plans Major Stake Reduction 
Samsung Electronics Poised for Massive Q4 Profit Surge on Soaring Memory Chip Prices 
Tokyo Electric Power Shares Surge as Kashiwazaki-Kariwa Nuclear Reactor Restart Nears 
Samsung to Double AI-Powered Mobile Devices with Google Gemini in Global AI Race 
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook 
BTIG Initiates Buy on SoftBank as AI and Robotics Strategy Gains Momentum 
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
Mercedes-Benz to Launch Advanced Urban Self-Driving System in the U.S., Challenging Tesla FSD 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Dublin, Oct. 24, 2017 -- The "Global Regenerative Medicines Market" report has been added to Research and Markets' offering.
Regenerative medicine is a branch of medicine involved with the repair or replacement of damaged tissues or organs. The field uses various strategies like the cell therapy, gene therapy and tissue engineering among others to replace the missing or damaged tissue or organ.
These also include the implantable medical devices. Regenerative medicine offers a treatment option for the incurable diseases such as cardiac diseases, immune-oncology and orphan diseases among others.
The gene therapy involves modulation of the target gene. It involves either the replacement, modification, silencing or introduction of the desired gene into the patient's body. Gene therapy may be done in vivo, where the gene is transferred to cells inside the body.
It may also be done ex vivo where the gene is incorporated into the cells outside the body which are then transferred into the patient's body. Cell therapy involves the administration of living non genetically modified cells into the patient's body. These cells multiply to replace or repair the damaged organ or tissue.
The cells used could be allogenic or autogenic. Tissue engineering technique involves biomaterials, biologically active molecules, cells, tissues or scaffolds.
Key Topics Covered:
Executive Summary
1 Report Scope
2 Market Overview
3 Market Dynamics
4 Competitive Insights
5 Industry Insights
- Regulatory Scenario
- Patent Landscape
6 Global Regenerative Medicine Market, By Therapy
- Cell Therapy
- Gene Therapy
- Tissue Engineering
7 Global Regenerative Medicine Market, by Product
8 Global Regenerative Medicine Market, By Application
- Orthopaedic
- Cardiology
- Wound Healing
- Diabetes
- Immuno-Oncology
- Others
9 Global Regenerative Medicine Market, By Geography
10 Company Profiles
- Acelity
- Athersys
- Cellular Biomedicine Group
- Cytori Therapeutics Inc.
- Integra LifeSciences
- Mesoblast
- MiMedx
- Novartis AG
- Nuvasive
- Organogenesis
- Osiris Therapeutics
- Stryker
- Terumo Corporation
- TiGenix
- Tissue Regenix
- Vericel Corporation
- Viacyte
- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/research/wsw6m5/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals
